Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

[Congenital amegakaryocytic thrombocytopenia: indication for allogeneic stem cell transplantation].

de Vries DS, Bruin MC, Bierings M, Révész T.

Ned Tijdschr Geneeskd. 2000 Aug 12;144(33):1596-8. Dutch.

PMID:
10965369
2.

Haematopoietic stem cell transplantation for amegakaryocytic thrombocytopenia.

Lackner A, Basu O, Bierings M, Lassay L, Schaefer UW, Révész T, Havers W, Kremens B.

Br J Haematol. 2000 Jun;109(4):773-5.

PMID:
10929028
3.

Engraftment of unrelated donor stem cells in children with familial amegakaryocytic thrombocytopenia.

MacMillan ML, Davies SM, Wagner JE, Ramsay NK.

Bone Marrow Transplant. 1998 Apr;21(7):735-7.

4.

Peripheral stem cell transplantation in a child with amegakaryocytic thrombocytopenia.

Yeşilipek, Hazar V, Küpesiz A, Yegin O.

Bone Marrow Transplant. 2000 Sep;26(5):571-2.

5.

Advances in the understanding of congenital amegakaryocytic thrombocytopenia.

Ballmaier M, Germeshausen M.

Br J Haematol. 2009 Jun;146(1):3-16. doi: 10.1111/j.1365-2141.2009.07706.x. Epub 2009 Apr 21. Review.

PMID:
19388932
6.

Allogeneic stem cell transplantation for patients with congenital amegakaryocytic thrombocytopenia (CAT).

Al-Ahmari A, Ayas M, Al-Jefri A, Al-Mahr M, Rifai S, El-Solh H.

Bone Marrow Transplant. 2004 Apr;33(8):829-31.

PMID:
14968137
7.

Reduced intensity hematopoietic stem-cell transplantation across human leukocyte antigen barriers in a patient with congenital amegakaryocytic thrombocytopenia and monosomy 7.

Steele M, Hitzler J, Doyle JJ, Germeshausen M, Fernandez CV, Yuille K, Dror Y.

Pediatr Blood Cancer. 2005 Aug;45(2):212-6. Review.

PMID:
15782403
8.

Bone marrow transplantation in two children with congenital amegakaryocytic thrombocytopenia.

Henter JI, Winiarski J, Ljungman P, Ringdén O, Ost A.

Bone Marrow Transplant. 1995 May;15(5):799-801. Erratum in: Bone Marrow Transplant 1996 Aug;18(2):487.

PMID:
7670411
9.

Congenital amegakaryocytic thrombocytopenia: a retrospective clinical analysis of 20 patients.

King S, Germeshausen M, Strauss G, Welte K, Ballmaier M.

Br J Haematol. 2005 Dec;131(5):636-44.

PMID:
16351641
10.

Successful bone marrow transplantation in a patient with c-mpl-mutated congenital amegakaryocytic thrombocytopenia from a carrier donor.

Muraoka K, Ishii E, Ihara K, Imayoshi M, Miyazaki S, Hara T, Hamasaki Y.

Pediatr Transplant. 2005 Feb;9(1):101-3.

PMID:
15667621
11.

Prolonged isolated thrombocytopenia after hematopoietic stem cell transplantation: morphologic correlation.

Bielski M, Yomtovian R, Lazarus HM, Rosenthal N.

Bone Marrow Transplant. 1998 Dec;22(11):1071-6.

12.

Congenital amegakaryocytic thrombocytopenia: clinical presentation, diagnosis, and treatment.

Ballmaier M, Germeshausen M.

Semin Thromb Hemost. 2011 Sep;37(6):673-81. doi: 10.1055/s-0031-1291377. Epub 2011 Nov 18. Review.

PMID:
22102270
13.

Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.

Kiehl MG, Kraut L, Schwerdtfeger R, Hertenstein B, Remberger M, Kroeger N, Stelljes M, Bornhaeuser M, Martin H, Scheid C, Ganser A, Zander AR, Kienast J, Ehninger G, Hoelzer D, Diehl V, Fauser AA, Ringden O.

J Clin Oncol. 2004 Jul 15;22(14):2816-25.

PMID:
15254049
14.

Unrelated bone marrow transplant for congenital amegakaryocytic thrombocytopenia: report of two cases and review of the literature.

Frangoul H, Keates-Baleeiro J, Calder C, Manes B, Crossno C, Castaneda VL, Domm J.

Pediatr Transplant. 2010 Jun;14(4):E42-5. doi: 10.1111/j.1399-3046.2009.01131.x. Epub 2009 Mar 10.

PMID:
19490489
15.

Congenital amegakaryocytic thrombocytopenia--report of a new c-mpl gene missense mutation.

Passos-Coelho JL, Sebastião M, Gameiro P, Reichert A, Vieira L, Ferreira I, Miranda N, Guimarães A, Leal-da-Costa F, Abecasis MM.

Am J Hematol. 2007 Mar;82(3):240-1.

16.

Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.

Maury S, Balère-Appert ML, Chir Z, Boiron JM, Galambrun C, Yakouben K, Bordigoni P, Marie-Cardine A, Milpied N, Kanold J, Maillard N, Socié G; French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).

Haematologica. 2007 May;92(5):589-96.

17.

Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose.

Dominietto A, Raiola AM, van Lint MT, Lamparelli T, Gualandi F, Berisso G, Bregante S, Frassoni F, Casarino L, Verdiani S, Bacigalupo A.

Br J Haematol. 2001 Jan;112(1):219-27.

PMID:
11167808
18.

Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.

Meisel R, Laws HJ, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Schmitz M, Fischer J, Göbel U, Enczmann J, Dilloo D.

Biol Blood Marrow Transplant. 2007 Nov;13(11):1338-45. Epub 2007 Sep 21.

19.

Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.

Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Qi DG, Sun AH, Zeng DF, Liu H, Gong Y, Wang QY.

Biol Blood Marrow Transplant. 2009 Feb;15(2):266-73. doi: 10.1016/j.bbmt.2008.11.029. Erratum in: Biol Blood Marrow Transplant. 2009 Apr;15(4):521.

20.

Severe acute graft-versus-host disease after T-cell depleted allogeneic stem cell graft from a second donor caused by persisting T-cells from the first donor.

Wiesmann A, Bader P, Bamberg M, Faul C, Kanz L, Einsele H.

Bone Marrow Transplant. 2003 Sep;32(5):511-3.

PMID:
12942098

Supplemental Content

Support Center